Deep Tech

Meta’s Hypernova Smart Glasses: Features, Price & What to Expect

At under US$1,000, Hypernova isn’t just eyewear—it’s Meta’s push to make AR feel ordinary.

Updated

January 8, 2026 6:34 PM

Closeup of the Ray-Ban logo and the built-in ultra-wide 12 MP camera on a pair of new Ray-Ban Meta Wayfarer smart glasses. PHOTO: ADOBE STOCK

Meta is preparing to launch its next big wearable: the Hypernova smart glasses. Unlike earlier experiments like the Ray-Ban Stories, these new glasses promise more advanced features at a price point under US$1,000. With a launch set for September 17 at Meta’s annual Connect conference, the Hypernova is already drawing attention for blending design, technology and accessibility.  

In this article, let’s take a closer look at Hypernova’s design, features, pricing and the challenges Meta faces as it tries to bring smart glasses into everyday life.

Why Hypernova matters

Meta’s earlier Ray-Ban glasses offered cameras and audio but no display. Hypernova changes that: The glasses will ship with a built-in micro-display, giving wearers quick access to maps, messages, notifications and even Meta’s AI assistant. It’s a step toward everyday AR that feels useful and natural, not experimental.

Perhaps most importantly, the price makes them attainable. While early estimates placed the cost above US$1,000, Meta has committed to a launch price of around US$800. That’s still premium, but it moves AR smart glasses into reach for more consumers.  

Design and build

Hypernova weighs about 70 grams, roughly 20 grams heavier than the Ray-Ban Meta models. The added weight likely comes from added components like the new display and extra sensors.  

To keep the glasses stylish, Meta continues its partnership with EssilorLuxottica, the company behind Ray-Ban and Prada eyewear. Thicker frames—especially Prada’s designs—help hide the hardware like chips, microphones and batteries without making the glasses look oversized.

The glasses stick close to the classic Ray-Ban silhouette but feature slightly bulkier arms. On the left side, a touch-sensitive bar lets users control functions with taps and swipes. For example, a two-finger tap can trigger a photo or start video recording.

Expected features of Hypernova  
Integrated display:  

Hypernova introduces something the earlier Ray-Ban glasses never had: a display built right into the lens. In the bottom-right corner of the right lens, a small micro-screen uses waveguide optics to project a digital overlay with about a 20° field of view. This means you can glance at turn-by-turn directions, check a notification or quickly consult Meta’s AI assistant without pulling out your phone. It’s discreet, practical and a major step up from the older models, which were limited to capturing photos and videos, handling calls and playing music via speakers.  

Gesture controls with neural wristband:  

Alongside the glasses comes the Ceres wristband, a companion device powered by electromyography (EMG). The band picks up the tiny electrical signals in your wrist and fingers, translating them into commands. A pinch might let you select something, a wrist flick could scroll a page, and a swipe could move between screens. The idea is to avoid clunky buttons or having to talk to your glasses in public. Meta has also been experimenting with handwriting recognition through the band, though it’s not clear if that feature will be ready in time for launch.  

Built-in gaming:  

Meta doesn’t just want Hypernova to be useful—it wants it to be fun. Code found in leaked firmware revealed a small game called Hypertrail. It looks to borrow ideas from the 1981 arcade shooter Galaga, letting wearers play a simple, retro-inspired game right through their glasses. It’s not the main attraction, but it shows Meta is trying to make Hypernova feel more like a playful everyday gadget rather than just a piece of serious tech.  

App ecosystem:  

Hypernova runs on a customized version of Android and pairs with smartphones through the Meta View app. Out of the box, it should support the basics: calls, music and message notifications. Leaks suggest several apps will come preinstalled, including Camera, Gallery, Maps, WhatsApp, Messenger and Meta AI. A Qualcomm processor powers the whole setup, helping it run smoothly while keeping energy demands reasonable.  

Meta is also trying to bring in outside developers. In August 2025, CNBC reported that the company invited third-party developers—especially in generative AI—to build experimental apps for Hypernova and the Ceres wristband. The Meta Connect 2025 agenda even highlights sessions on a new smart glasses SDK and toolkit. The push shows Meta’s interest in making Hypernova more than just a device; it wants a broader platform with apps that go beyond its own first-party software.  

Pricing strategy: Why under US$1,000 matters

During development, Hypernova was rumored to cost as much as US$1,400. By pricing it around US$800, Meta signals that it wants adoption more than profit. The company is keeping production limited (around 150,000 units), showing it sees this as a market test rather than a mass rollout. Still, the sub-US$1,000 price tag makes advanced AR far more accessible than before.

Challenges ahead

Despite its promise, Hypernova may still face hurdles. The Ceres wristband can struggle if worn loosely, and some testers have reported issues based on which arm it’s worn on or even when wearing long sleeves. In short, getting EMG input right for everyone will be critical.

Privacy is another major concern. In past experiments, researchers hacked Ray-Ban Meta glasses to run facial recognition, instantly identifying strangers and pulling personal info. Meta has added guidelines, like a recording indicator light, but critics argue these measures are too easy to ignore. Moreover, data captured by smart glasses can feed into AI training, raising questions about consent and surveillance.

The bottom line

The Meta Hypernova smart glasses mark a turning point in wearable tech. They’re lighter and more stylish than bulky AR headsets, while offering real-world features like navigation, messaging and hands-free control. At under US$1,000, they aim to make AR glasses more than a luxury gadget—they’re a step toward everyday use.

Whether Hypernova succeeds will depend on how well it balances style, usability and privacy. But one thing is clear: Meta is betting that always-on, glanceable AR can move from science fiction to daily life.

Keep Reading

Startups

How CYBERTONGUE® Is Taking the Guesswork Out of Dairy Testing

The Canberra biotech startup is helping processors detect spoilage risks before milk reaches the shelf.

Updated

August 13, 2026 1:01 AM

CYBERTONGUE® Food Testing System, developed by PPB Technology. IMAGE: PPB Technology

Anyone who has opened a carton of milk before its expiry date only to find that it smells off or tastes bitter has experienced the problem firsthand. For dairy processors, the same issue can play out across thousands of litres. Milk may pass routine quality checks, make it through production and still spoil before reaching the end of its expected shelf life.  

CYBERTONGUE®, a biosensing platform, is designed to give dairy processors an earlier warning.  

Developed by Canberra-based biotech startup PPB Technology, the compact food testing system allows processors to analyse milk on-site and receive results within minutes. Its first commercial application detects protease, an enzyme linked to spoilage, shorter shelf life and production losses across dairy products.  

Dairy companies already test milk for fat, protein, bacteria, antibiotics and other indicators. Samples from individual farms may be sent to central laboratories, while tanker loads are tested again when they reach processing plants. These checks provide useful information, but they do not always show whether milk will remain stable in a UHT carton, meet a supermarket’s shelf-life requirements or produce the expected amount of cheese.  

Even after heat treatment, protease can continue affecting milk. For processors making UHT milk, fresh milk or mature cheese, that creates a costly blind spot.  

“Right now, dairy processors are working blind on this,” PPB Technology founder Stephen Trowell told Ventureport. “It’s becoming more of a problem as customers expect longer shelf lives and higher quality.”  

CYBERTONGUE® uses engineered biosensing proteins that emit blue and green light. The balance between the two colours changes when the protein reacts with a target substance. The reader measures that shift and calculates how much of the target is present.  

CYBERTONGUE® software displaying the results of a completed raw milk assay. IMAGE: PPB TECHNOLOGY

Trowell describes himself as a protein engineer at heart. He spent around three decades at CSIRO, Australia's national science and technology agency, and close to four decades in research before becoming a startup founder. The technology behind CYBERTONGUE® grew out of years of biological research, including earlier experiments involving wine aromas and explosives detection.

The PPB Technology team with founder Stephen Trowell. IMAGE: PPB TECHNOLOGY

PPB initially developed its technology to measure plasmin, an enzyme derived from cows. After feedback from the dairy industry, the company shifted its focus to bacterial proteases, which were identified as a more pressing spoilage problem. The platform can make some existing tests faster, but PPB chose to focus first on a measurement previously unavailable to processors.  

“Where we’ve chosen to lead is with a measurement nobody else can do at all,” he said. “The blue ocean, if you like.”  

That focused entry point shapes PPB’s wider strategy. CYBERTONGUE® could eventually test for lactose, allergens, microbial toxins and other targets. Yet launching everything at once would stretch a six-person company too far. Protease gives it a clear route into dairy, where the financial value is easier to demonstrate.  

A processor that detects high protease activity may redirect a batch of milk away from long-life products and use it for yoghurt, curd or another product where the enzyme causes less damage. PPB also says its tests can help trace problems in the milk supply and detect biofilms on processing equipment, allowing factories to take corrective cleaning measures.  

Fresh milk presents another sizeable opportunity, with the global market estimated at around US$81 billion in 2026 and projected to grow at 6.83% annually through 2035. At that scale, even small gains in shelf-life consistency could prevent substantial losses. Supermarkets often require milk to have a minimum amount of shelf life remaining on delivery. Products that fall short may be rejected, discounted or discarded at the processor’s expense. While Australian processors typically aim for a shelf life of 19 to 21 days, they do not always achieve it. CYBERTONGUE® could help them reach that target more consistently.  

Cheese producers face a related issue. Protease can create bitter flavours in hard cheeses and reduce production yield. Cheesemakers add another enzyme, chymosin, during production, often without knowing how much protease activity is already present in the milk. Better information could help them adjust the process and get more value from the same raw material.  

PPB sells the reader as laboratory equipment, but its long-term business model centres on repeat testing. Customers buy the machine, then purchase a PPB reagent cartridge each time they run an assay. Future tests are intended to work on the same reader, making the system more useful as the catalogue expands.  

CYBERTONGUE®’s compact design reflects PPB’s focus on practical onsite testing. The device is small enough to fit into two cupped hands and comes with a tablet running PPB’s software.  

An operator inserts a sample into a CYBERTONGUE® testing device during an on-site milk analysis. PHOTO: PPB TECHNOLOGY

At the time of the interview, 13 to 15 systems had been installed with paying customers. PPB had made sales in 11 countries across five continents, with Europe as its largest market.  

Trowell describes PPB as “born global”. While Australia and New Zealand have sophisticated dairy industries, Trowell thinks CYBERTONGUE® may offer even more value in regions where milk quality is less consistent, transport routes are longer or refrigeration is harder to maintain.  

Trowell also believes PPB has a strong competitive moat, with the combination of manufacturing both the hardware and consumable reagents. Patents form one layer, but he does not consider legal protection sufficient on its own. A competitor would need expertise in protein engineering, reagent production, optical hardware, software and dairy processing.  

Calibration adds another barrier. For each new box of reagents, PPB securely uploads the required calibration data to the customer’s machine. A third party could not simply manufacture a cartridge with the same dimensions and expect it to work correctly.  

“We own the whole stack,” Trowell said, referring to everything from the sensing molecule to the hardware, software and cloud platform.  

That said, he accepts that no technology is impossible to copy. His view is that PPB’s mix of scientific knowledge, integrated system and experience in dairy gives it enough of a head start to build a meaningful position before competitors catch up.  

The technology could eventually reach beyond food. Trowell sees possible uses in environmental testing, veterinary care and medical diagnostics, including the analysis of blood, serum or saliva. PPB has already discussed potential applications with organisations outside the food industry.  

For now, however, moving directly into clinical diagnostics would create more risk than opportunity. Medical products can require years of trials, extensive regulatory work and large development budgets. PPB would also need to build new sales channels and choose between many possible clinical uses without knowing which one would attract the strongest demand.  

For these reasons, food testing offers PPB a clearer path. The regulatory barriers are generally lower, customers have immediate operational problems, and PPB has already built relationships in dairy. Once the platform has proved itself commercially, the company could enter other sectors through partnerships or licensing.  

Trowell has held that view for years. The immediate goal is to build a successful food testing company rather than chase the prestige often attached to medical biotechnology.  

The opportunity may also expand as food production becomes more complex. Dairy factories increasingly process oat, soy and other alternatives on equipment that also handles cow’s milk. This creates cross-contamination and allergen risks, offering another potential use for CYBERTONGUE®.  

PPB still has plenty to prove. It must secure repeat reagent orders, convert early trials into wider deployments and expand its test catalogue without compromising accuracy. Scaling an integrated biotech hardware business across international markets will not be simple.  

Still, its approach offers a useful lesson for other deep-tech startups. Instead of beginning with every possible application, PPB picked a specific problem that costs customers money today. It built a product around that pain point, then used the same technology as the foundation for a broader platform.  

As Trowell put it, customers “need it fast, and they need it right.” CYBERTONGUE® is betting that food testing can deliver both.